StockData
Tevogen Inc. logo

Tevogen Inc. (TVGN) stock

TVGNNasdaqBiological Products, (No Diagnostic Substances)Fiscal year ends December 31Also trades as TVGNW
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 16, 2026Score 4/30
$5.69−0.53 (-8.52%)

Close on Nov 17, 2026Market cap $37.05MP/E –Yield –

Tevogen enterprise value

Enterprise value is market cap plus debt, minus cash: the value of the whole business to all its investors.

Tevogen's enterprise value was $24.45M on Nov 11, 2026, against $86.05M a year earlier. Over the last 3 years it ranged from $17.62M to $931.35M, with a median of $104.04M.

Enterprise Value at the end of each year

PeriodPeriod endValueChange
2026Nov 11, 2026$24.45M-62.0%
2025Dec 31, 2025$64.32M-62.9%
2024Dec 31, 2024$173.57M+737.3%
2023Apr 28, 2023$20.73M–

More Tevogen figures

See a number that looks wrong?